✦ LIBER ✦

CN2 ECONOMIC EVALUATION OF NEW POLY-CHEMOTHERAPY REGIMENS AS ALTERNATIVES TO CISPLATIN PLUS PACLITAXEL IN ADVANCED NON-SMALL CELL LUNG CANCER

✍ Scribed by N Neymark; J van Meerbeeck; E Smit; P Lianes; G Giaccone

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine–cisplatin–

✍ Cappuzzo, F 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Phase II study of Gemcitabine, Ifosfamid

✍ Castellano, D; Lianes, P; Arcediano, A; Gómez-Martin, C; Ciruelos, E; Bezares, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Cisplatin and vinorelbine as second-line

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A phase II trial of weekly chemotherapy

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

CN5 EXPLORATORY ECONOMIC EVALUATION OF A

✍ M Gyldmark; U Gatzemeier; M Nicolson; N Latimer; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Paclitaxel plus cisplatin is as effectiv

✍ Sarah Danson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB